Lazard Ltd
NYSE:LAZFinancial - Capital Markets
+$0.45 today
- Market cap
- $3.85B
- Beta
- 1.41
- P/E (TTM)
- 15.7
- EPS (TTM)
- $2.79
- Dividend yield
- 4.58%
Volume 1.38M
Average 1.53M
LAZ EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Lazard LtdNYSE: LAZ
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA declines year over year
Q3 FY2026 EBITDA of $76.96M fell 39.0% year over year, behind the -23.9% change in trailing-twelve-month EBITDA. Sequentially, it rose 71.1% from the prior quarter. Over 3 fiscal years it compounded at -13.8% a year.
Context
- EBITDA amounted to 14.1% of revenue in FY2025, down 2.4 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $199.96M (-55.5%) for the fiscal year ending Dec 2026, a slowdown from the -12.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $76.96M+71.1% QoQ
- Last fiscal yearDec 2025
- $449.41M-12.0% YoY
- LTMSep 2026
- $358.38M-23.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -39.0% | -67.4% | -28.4 pp |
| 1 year | -12.0% | -55.5% | -43.5 pp |
| 3-year CAGR | -13.8% | +10.7% | +24.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 449.41M USD
- Year-over-year change
- -12.0%
- 4-year CAGR
- -16.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 449.41M | -12.0% |
| FY2024 | 2024-12-31 | 510.82M | +1159.1% |
| FY2023 | 2023-12-31 | 40.57M | -94.2% |
| FY2022 | 2022-12-31 | 701.39M | -23.5% |
| FY2021 | 2021-12-31 | 917.02M | — |
EBITDA vs competitors
How LAZ compares with its peers on the latest reported figures
- LAZ's LTM Sep 2026 EBITDA of $358.38M is the 10th highest of the 11 companies compared; the peer median is $567.62M.
- Its year-over-year change of -23.9% is the lowest of 11, against a peer median of +26.6%.
- EBITDA amounts to 10.6% of revenue for LAZ, versus a peer median of 24.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.15B | +7.4% | +30.0% | 18.6% | |
| LTM Jun 2026 | $2.77B | +48.3% | +56.6% | 1.8% | |
| LTM Jun 2026 | $1.7B | -1.2% | +10.0% | 41.7% | |
| LTM Sep 2026 | $707.61M | +128.4% | +5.4% | 32.0% | |
| LTM Sep 2026 | $573.43M | +33.9% | +24.3% | 16.5% | |
| LTM Jun 2026 | $561.82M | +5.0% | +18.0% | 30.2% | |
| LTM Jun 2026 | $515.58M | +112.6% | +35.7% | 24.5% | |
| LTM Jun 2026 | $443.13M | +32.1% | +13.8% | 23.5% | |
| LTM Sep 2026 | $363.02M | +17.1% | +3.3% | 41.4% | |
| LTM Sep 2026 | $358.38M | -23.9% | -13.8% | 10.6% | |
| LTM Sep 2026 | $349.59M | +21.1% | +14.8% | 21.3% | |
| Peer median (excluding LAZ) | $567.62M | +26.6% | +16.4% | 24.0% | |
Competitors are the stored peer set for LAZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.27B | 2.83B | 2.55B | 3.09B | 3.19B |
| Cost of Revenue | 1.9B | 1.66B | 1.95B | 2B | 2.17B |
| Gross Profit | 1.37B | 1.17B | 605.13M | 1.08B | 1.01B |
| Gross Margin | 42.0% | 41.4% | 23.7% | 35.1% | 31.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 379M | 384.87M | 430.66M | 426.66M | 118.49M |
| Operating Expenses | 648.56M | 652.34M | 685.09M | 696.62M | 597.78M |
| Depreciation & Amortization | 112.4M | 103.02M | 42.85M | 36.28M | 34.19M |
| EBITDA | 917.02M | 701.39M | 40.57M | 510.82M | 449.41M |
| EBITDA Margin | 28.1% | 24.8% | 1.6% | 16.6% | 14.1% |
| Operating Income | 723.85M | 516.85M | (79.96M) | 386.47M | 415.32M |
| Operating Margin | 22.1% | 18.3% | -3.1% | 12.5% | 13.0% |
| Interest Income | 5.55M | 29.46M | 42.02M | 53.6M | 38.49M |
| Interest Expense | 80.77M | 81.52M | 77.67M | 88.07M | 87.62M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (87.72M) |
| Income Before Tax | 723.85M | 516.85M | (79.96M) | 386.47M | 327.6M |
| Pre-Tax Margin | 22.1% | 18.3% | -3.1% | 12.5% | 10.3% |
| Income Tax Expense | 181.3M | 124.37M | (22.65M) | 99.76M | 76.58M |
| Net Income | 528.06M | 357.52M | (75.48M) | 279.91M | 236.83M |
| Net Margin | 16.2% | 12.7% | -3.0% | 9.1% | 7.4% |
| EPS (Basic) | 4.90 | 3.68 | (0.90) | 2.93 | 2.43 |
| EPS (Diluted) | 4.63 | 3.51 | (0.90) | 2.68 | 2.17 |
| Weighted Avg Shares | 106.04M | 95.66M | 88.99M | 93.14M | 97.48M |
| Weighted Avg Shares (Diluted) | 113.68M | 101M | 88.99M | 102.39M | 106.34M |
Lazard Ltd
NYSE:LAZ
Intrinsic Alpha fair value
Locked
Current Price
$39.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.